Topical Hemostat Market Report 2025

The topical hemostat market size has grown strongly in recent years. It will grow from $4.96 billion in 2024 to $5.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth during the historic period is driven by rising healthcare spending, a higher number of minimally invasive procedures, an increase in chronic disease cases, growing demand for surgical interventions, and greater interest in biodegradable products.

The topical hemostat market size is expected to see strong growth in the next few years. It will grow to $7.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. Growth in the forecast period is expected to result from the expanding global aging population, a rise in ambulatory surgical centers, increased emphasis on patient outcomes, growing use of adhesive-hemostat combinations, and wider adoption of bio-based materials. Key trends anticipated include innovations in hemostatic technologies, the incorporation of digital health solutions, improvements in delivery systems, the creation of combination products, and the use of robotics in managing hemostasis.

The increasing number of surgical procedures is anticipated to drive the growth of the topical hemostat market in the coming years. Surgical procedures involve medical interventions performed by surgeons using manual techniques and specialized instruments to diagnose, treat, or repair injuries, diseases, or bodily abnormalities. The frequency of these procedures is rising significantly as the global population ages rapidly, leading to a higher occurrence of age-related health issues that require surgical treatment to enhance quality of life and manage chronic conditions. Topical hemostats are utilized during surgeries to help surgeons quickly control bleeding at the surgical site, improve visibility, reduce blood loss, and lower the risk of postoperative complications. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based non-governmental organization, reported that plastic surgeons performed 11.2% more procedures in 2022 compared to 2021, with over 14.9 million surgical and 18.8 million non-surgical procedures conducted worldwide. Consequently, the rising number of surgical procedures is fueling the expansion of the topical hemostat market.

Increasing healthcare expenditure is expected to support the growth of the topical hemostat market going forward. Healthcare expenditure encompasses the total spending on medical services, treatments, and health-related resources within a specified timeframe. The growth in healthcare spending, driven by an aging population, results in increased demand for medical services, long-term care, and treatments for age-related conditions, which collectively place greater financial strain on healthcare systems. This rise in expenditure boosts the demand for topical hemostats by enabling more surgical interventions, promoting the adoption of advanced medical technologies, and improving global healthcare access. Increased funding allows hospitals to invest in efficient bleeding control solutions, particularly for minimally invasive and outpatient surgeries. For instance, according to the American Medical Association, a US-based professional association, health spending in the U.S. increased by 7.5% in 2023, reaching $4.9 trillion or $14,570 per person, marking a significant rise compared to the 4.6% growth seen in 2022. Therefore, the escalating healthcare expenditure is driving the growth of the topical hemostat market.

Key players in the topical hemostat market are concentrating on developing innovative products such as hemostatic sealing patches to improve bleeding control during surgeries by offering faster, more effective, and targeted hemostasis at the wound site. A hemostatic sealing patch is a medical device made from materials like collagen or fibrin that rapidly stops bleeding by adhering to tissue and facilitating clot formation during surgery. For example, in November 2023, Ethicon, Inc., a US-based company specializing in surgical technologies, launched the ETHIZIA Hemostatic Sealing Patch, a new synthetic polymer-based adjunctive hemostat clinically shown to stop severe bleeding on internal organs quickly. In clinical trials, ETHIZIA halted bleeding within 30 seconds in 80% of patients, which is six times faster than leading fibrin sealant patches. The patch is uniquely designed to be effective on both sides and highly adaptable, allowing it to be trimmed, rolled, pulled apart, or customized for use in both open and minimally invasive surgeries. It dehydrates blood and speeds coagulation through a gelatin carrier infused with polyoxazoline polymer, forming a strong adhesive hydrogel that bonds firmly to tissue.

Major players in the topical hemostat market are Pfizer Inc., Johnson & Johnson, Medtronic Plc, Medline Industries, Becton Dickinson and Company, Stryker Corporation, Baxter International, Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Samyang Holdings, Integra LifeSciences, Medicom Group, B. Braun SE, Advanced Medical Solutions Group Plc, Axio Biosolutions, Marine Polymer Technologies Inc, Hangzhou Singclean Medical Products, Neo Modulus Medical Sci-Tech, Tricol Biomedical, HemCon Medical Technologies Inc., Hemostasis LLC, KATSAN Medical Devices, Zhejiang Perfectseal New Materials.

North America was the largest region in the topical hemostat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in topical hemostat report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the topical hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The topical hemostat market consists of sales of physical hemostats, active coagulation agents, synthetic and hemisynthetic agents, natural and plant-based agents, and chitosan-based dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The topical hemostat market research report is one of a series of new reports that provides topical hemostat market statistics, including topical hemostat industry global market size, regional shares, competitors with a topical hemostat market share, detailed topical hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the topical hemostat industry. This topical hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A topical hemostat is a specialized medical product applied directly to a bleeding area during surgery or trauma to quickly promote clotting and control bleeding. These agents act locally by forming a physical barrier, triggering the body’s natural clotting processes, or providing a structure that supports platelet clumping and fibrin formation to stop blood flow.

The primary types of topical hemostats include fibrin, thrombin, cellulose, collagen, gelatin, adhesives, and others. Fibrin hemostats are biologically derived agents that replicate the final stages of the coagulation process by combining fibrinogen and thrombin to form a stable clot at the bleeding site. These products are distributed through channels such as direct sales, distributors, hospital pharmacies, and online platforms, and they find application in various surgeries including general, neurosurgery, vascular, and cardiovascular procedures. Key end users comprise hospitals, ambulatory surgical centers, and other healthcare facilities.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.